Premier Health Enters Into Binding Agreement to Acquire Leading Ontario Agency Canadian Health Care Agency

Premier Health Enters Into Binding Agreement to Acquire Leading Ontario Agency Canadian Health Care Agency

Premier Health of America Inc. (TSXV: PHA ) (" Premier Health " or the " Corporation "), a leading Canadian Healthtech company, is pleased to announce that it has entered this day into a share purchase agreement (the " SPA ") to acquire, through a newly created wholly owned federally incorporated subsidiary, 13822214 Canada (" CanCo "), 100% of the outstanding shares of Umana Holdings Inc. (" Umana ") and its wholly-owned subsidiary Canadian Health Care Agency, (" CHCA ") for a total consideration comprised between C$10.5M to C$14.5M (the " Purchase Price "), payable in cash, depending on the achievement of performance objectives (the " Transaction "), minus indebtedness, as more fully detailed below. As a result of the Transaction and a corporate reorganization, CHCA will become a wholly owned subsidiary of the Corporation. The Corporation will continue the business of CHCA which consists in providing specialized nursing services.

"The acquisition of CHCA starts our expansion outside of the province of Quebec and consolidates our market position in Canada's northern regions" Said Martin Legault, CEO of Premier Health. " In addition, the Cambridge based agency provides us with a good management infrastructure in Ontario that will serve as a base to continue our expansion in this province. This is a strategy we are expecting to follow in other provinces as well."

CHCA is the primary provider to Indigenous Services Canada ("ISC") for nursing services to remote and semi-remote Indigenous communities in both Ontario and Alberta. In addition, CHCA provides nurses services as a backup provider to ISC for these communities in Manitoba. CHCA is based in Cambridge, Ontario, and was founded in 2001 in response to severe staffing shortages in Canada's northern regions. CHCA started its operations in Northern Ontario and quickly expanded its activities to providing services in Nunavut and Northern Manitoba. CHCA currently has over 200 active and specially trained Registered Nurses and Nurse Practitioners in its organization. For the fiscal year ending January 31, 2022, CHCA generated revenues of C$34.5M (of which an estimated C$10.3M were Covid related non-recurring isolation revenues), an EBITDA of C$6.4M (of which an estimated C$3.0M was Covid related non-recurring isolation EBITDA) and a net income of C$4.6M (of which an estimated C$3.0M was Covid related non-recurring isolation net income).

"Our objective is to continue building on our foundation of offering superior care and services to our communities" Said Sharon Umana, CEO of CHCA "Teaming up with Premier Health is a natural fit for us that will allow us to capitalize on the strengths of our nurses and nurse practitioners into even more opportunities to provide care."

Transaction Details

CanCo has entered into the SPA with the shareholders of Umana to acquire all of the issued and outstanding shares of CHCA on a cash free and debt free basis for a total cash consideration of up to C$14.5M million, comprised of a C$10.5M cash payment less indebtedness at closing of the Transaction (the " Closing "), a C$Nil to C$3M deferred cash consideration payable over two years subject to the achievement of EBITDA objectives, and a C$Nil to C$1M deferred cash consideration payable one year after Closing, linked to isolation revenues if any. The Transaction is subject to working capital adjustments to be completed within 90 days following the Closing of the Transaction. The Transaction is subject to customary conditions precedent, including without limitation, receipt of any required approval and completion of satisfactory due diligence, and is expected to close on or about April 19, 2022. The Transaction is an arm's-length transaction, and Acumen Capital Partners acted as adviser for the Transaction.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb software platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services.

Non-GAAP Measures

Earnings before interest, taxes, depreciation, and amortization (" EBITDA "), is calculated as the net profit (loss), before acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation and stock-based compensation), interest expense, net of interest income and income tax expense.

For Further Information Please Contact   :

Mr. Jean-Robert Pronovost
Vice-President, Corporate Development
Premier Health of America Inc.
jrpronovost@premierhealth.ca / 1 800 231 9916

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PHA:CA
The Conversation (0)
Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announced today that the TSX Venture Exchange (" TSXV ") has accepted the Corporation's application for its normal course issuer bid (the " NCIB ") for a portion of its outstanding common shares (" Common Shares ") as appropriate opportunities arise from time to time. The Corporation's NCIB will be made in accordance with the requirements of the TSXV and applicable securities laws.

Pursuant to the NCIB, Premier Health may repurchase up to a maximum of 1,428,571 Common Shares representing approximately a value of $500,000 at the current market price and 7% of its public float, where the aggregate public float as at November 14, 2022, was 19,664,860 Common Shares. Purchases under the NCIB may be made through the facilities of the TSXV, based on the prevailing market price at the time of acquisition. The NCIB will be funded using existing cash resources and any Common Shares purchased under the NCIB will be cancelled.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Announces CFO Transition

Premier Health Announces CFO Transition

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, today announced that it is proceeding with a transition of the CFO functions and appoints Simon Belval as Interim Chief Financial Officer, effective immediately.

Simon Belval is a seasoned professional that has demonstrated strong abilities and leadership in finance and accounting functions including IFRS reporting, tax planning, financing, and risk management in different environments. He has held several leadership roles in the technology and fintech sectors and has developed over the years an expertise in managing strategic initiatives and special situations. He started his career as an external auditor and later acted as senior financial analyst for major organizations in Eastern Canada. Simon is a member of the Ordre des comptables professionnels agrées du Québec (CPA) and a Chartered Financial Analyst (CFA).

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Reports FY2022 Third Quarter Results

Premier Health Reports FY2022 Third Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its third quarter ended June 30, 2022.

Summary

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Reports FY2022 Second Quarter Results

Premier Health Reports FY2022 Second Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022.

Summary

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health of America

Premier Health Announces the Appointment of Giovanni Garay as Ontario General Manager

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announces the appointment of Giovanni Garay as Ontario General Manager, effective immediately.

"We are very excited to have Giovanni join Premier Health. His hiring follows our recent acquisition in Ontario, and he will be an important member of the Corporation's senior leadership team," said Martin Legault, Chief Executive Officer. "Giovanni's experience with large organisations will benefit Premier Health as we continue to expand our footprint in the province." he added.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Thermo Fisher Scientific Hosts 2024 Investor Day

Highlights Include the Company's Industry-Leading Businesses, Proven Growth Strategy, and Outstanding Long-Term Financial Outlook

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cleo Diagnostics

Cleo Commences U.S. Clinical Trials

Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to confirm the commencement of U.S. clinical trials for its ovarian cancer diagnostic blood test.

Keep reading...Show less
Truscreen

TruScreen Cervical Cancer Screening Test Outperforms Traditional Pap Smear in Saudi Arabia Study

TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce the preliminary publication, on 25 July 2024, of a study titled “Beyond Tradition: Investigating TruScreen’s Performance Versus Pap Smear in Cervical Cancer Detection” on Research Square1Link. The preliminary publication is subject to peer review.

Keep reading...Show less

Thermo Fisher Scientific to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 22 nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 8:30 a.m. (EDT).

You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Medtronic chairman and CEO Geoff Martha to speak at the Wells Fargo Healthcare Conference

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 .

Geoff Martha , Medtronic chairman and chief executive officer, will answer questions on the medtech industry and on the company beginning at approximately 11:55 a.m. EDT ( 12:55 p.m. CDT ).

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Cleo Diagnostics

Appendix 4E and 2024 Annual Report

Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to present its Annual Report.
Keep reading...Show less

Latest Press Releases

Related News

×